JieJun Wang

8.7k citations
123 papers · 7.3k · 1 hit paper · h-index 25

Impact in

  • Hepatology top 0.1%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • MicroRNA in disease regulation
    • Cancer, Hypoxia, and Metabolism

Papers in

JieJun Wang

114 papers receiving 7.2k citations

JieJun Wang's Hit Papers

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial 2008 · 5.1k citations
5.1k0+6+12Years since publication1k2k3k4k5k

Peers

JieJun Wang
Comparison fields: 5 of 115
  • Hepatology 4k
  • Cancer Research 521
  • Oncology 752
  • Pulmonary and Respiratory Medicine 489
  • Molecular Biology 899
Replace Li Xu with:
Li Xu China
Rong Guo China
Jun Akiba Japan
Xiujun Cai China
Hideki Iwamoto Japan
Baocai Xing China
Yuan Ji China
Zhenggang Ren China
Weidong Jia China
Ti Zhang China
JieJun Wang relative to Li Xu China Li Xu's profile →
Citations per field
00.5×1.5×2.1×
Li Xu · 1×
Citations per year

Countries citing papers authored by JieJun Wang

Since Specialization
Citations

This map shows the geographic impact of JieJun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JieJun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JieJun Wang more than expected).

Fields of papers citing papers by JieJun Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JieJun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JieJun Wang. The network helps show where JieJun Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside JieJun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with JieJun Wang Line = papers co-authored together JieJun Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
20085101
2 2018327
3 2009139
4 2013118
5 201077
6 202270
7 201266
8 201566
9 200859
10 201257
11 201757
12 201556
13 201855
14 201448
15 201445
16 201044
17 201342
18 200740
19 201439
20 201535

About JieJun Wang

JieJun Wang is a scholar working on Pulmonary and Respiratory Medicine, Neurology, Building and Construction, Cancer Research and Anesthesiology and Pain Medicine, having authored 123 papers that have together received 7.3k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (18 papers), Intracranial Aneurysms: Treatment and Complications (11 papers), Wood Treatment and Properties (8 papers), Advanced Memory and Neural Computing (8 papers), Structural Load-Bearing Analysis (8 papers), Optical Polarization and Ellipsometry (6 papers), Heat Transfer and Optimization (5 papers) and Pain Management and Opioid Use (5 papers). The work is most often cited by research in Hepatology (4k citations), Cancer Research (521 citations), Oncology (752 citations), Pulmonary and Respiratory Medicine (489 citations) and Molecular Biology (899 citations). JieJun Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Guanzhen Yu, Jun Pan, Keping Xie, Wenxing Qin, Te Liu, Yongyi Huang, Ying Chen, Ying Chen, Xi Wang and Ke Liu. Their work appears in journals such as Frontiers in Neurology, BMC Cancer, Medical Oncology, Oncotarget and Buildings.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact